1,200
Participants
Start Date
May 31, 2025
Primary Completion Date
November 30, 2027
Study Completion Date
November 30, 2027
Liquid biopsy
Serum protein profile, serum metabolic mass spectrometry, plasma cfDNA/cfRNA genomic and epigenomic assays, and serum tumor markers were performed. Patients were followed up for 3 years at a 3-month interval. Collect surgically removed colorectal cancer samples to construct PDX models if necessary.
Huashan Hospital, Shanghai
Huashan Hospital
OTHER